Competitive Dynamics Between MNC Imports and Domestic Manufacturing Ecosystems: Analyzing the India CAR T Cell Therapy Market Share Distribution
  The distribution of India CAR T Cell Therapy Market Share is currently characterized by a transitional phase, moving from an environment dominated by imported, ultra-expensive products to one led by cost-effective, indigenous innovation. Historically, the share belonged to international pharmaceutical giants (MNCs) whose FDA/EMA-approved therapies were accessed only by a tiny,...
0 التعليقات 0 المشاركات 135 مشاهدة 0 معاينة
MTSocial https://mtsocial.ir